All patients | OS (95% CI) | ●P value | TFS (95% CI) | ●P value | |
---|---|---|---|---|---|
Mesenchymal group | No | 61.89 (51.61–70.60) | 0.294 | 52.78 (42.78–61.82) | 0.285 |
Yes | 71.84 (60.71–80.32) | 63.64 (52.26–72.99) | |||
Patient sex | Female | 72.09 (6088–8059) | 0.131 | 67.94 (56.79–76.79) | 0.245 |
Male | 61.06 (51.04–69.63) | 59.35 (349.52–58.44) | |||
Donor sex | Female | 66.37 (54.58–75.77) | 0.561 | 56.63 (45.15–66.59) | 0.999 |
Male | 65.78 (55.18–74.45) | 57.66 (47.02–66.91) | |||
Sex-matched | Mismatched | 62.57 (50.93–72.19) | 0.458 | 50.76 (39.58–60.90) | 0.098 |
Matched | 68.72 (58.29–77.05) | 62.93 (52.49–71.69) | |||
ABO-matched | ABO-matched | 68.36 (58.15–76.58) | 0.248 | 60.49 (50.36–69.19) | 0.158 |
ABO-mismatched | 62.17 (50.43–71.90) | 51.65 (40.17–61.97) | |||
Source of transplant | BM | 72.82 (61.29–81.43) | 0.194 | 61.96 (50.18–71.73) | 0.492 |
PB | 62.21 (52.58–70.43) | 54.45 (44.95–63.01) | |||
Acute GvHD | No | 73.09 (62.21–81.30) | 0.490 | 58.17 (47.36–67.51) | 0.594 |
Yes | 67.64 (59.42–71.51) | 56.63 (46.41–65.62) | |||
Chronic GvHD | No | 64.29 (58.13–70.17) | 0.867 | 68.02 (59.27–76.23) | 0.341 |
Yes | 68.46 (59.19–76.39) | 73.46 (61.19–82.39) |